New patent expiration for Keryx Biopharms drug AURYXIA
Annual Drug Patent Expirations for AURYXIA Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. […]
New patent expiration for Keryx Biopharms drug AURYXIA Read Post »
Patent Expiration
New patent expiration for Upsher Smith drug FORTICAL
Annual Drug Patent Expirations for FORTICAL Fortical is a drug marketed by Upsher Smith Labs and is included in one
New patent expiration for Upsher Smith drug FORTICAL Read Post »
New patent expiration for Allergan drug LATISSE
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Allergan and is included in one NDA. It
Drug Patent Expirations for the Week of January 24, 2021
ORILISSA (elagolix sodium) Abbvie inc Patent: 7,462,625 Expiration: Jan 25, 2021 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of January 24, 2021 Read Post »
New patent expiration for Organon Sub drug BRIDION
Annual Drug Patent Expirations for BRIDION Bridion is a drug marketed by Organon Sub Merck and is included in one
New patent expiration for Organon Sub drug BRIDION Read Post »
New patent expiration for Abbvie Inc drug ORILISSA
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie Inc and is included in one NDA.
New patent expiration for Abbvie Inc drug ORILISSA Read Post »
New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED)
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one
New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED) Read Post »
New patent expiration for Eisai Inc drug HALAVEN
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA.
New patent expiration for Eisai Inc drug HALAVEN Read Post »
New patent expiration for Eisai Inc drug HALAVEN
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA.
New patent expiration for Eisai Inc drug HALAVEN Read Post »
